bibliographic entry 12414285 [be/12414285]
https://w3id.org/oc/corpus/be/12414285

is a

bibliographic reference

content

Siu, L. L, Shapiro, J. D, Jonker, D. J, Karapetis, C. S, Zalcberg, J. R, Simes, J, â¦ NCIC Clinical Trials Group and AGITG. (2012). Phase III randomized trial of cetuximab (CET) plus either brivanib alaninate (BRIV) or placebo in patients (pts) with metastatic (MET) chemotherapy refractory K-RAS wild-type (WT) colorectal carcinoma (CRC): The NCIC Clinical Trials Group and AGITG CO.20 trial. ASCO Meeting Abstracts, 30(4_suppl), 386.

references

https://w3id.org/oc/corpus/br/8212788